[PDF] Angiotensin Receptor Blockers and the Risk of Cancer. Statement from the British Hypertension Society July 2010

Source:
British and Irish Hypertension Society - BIHS
Publisher:
British and Irish Hypertension Society (BIHS)
Publication date:
13 July 2010

Abstract

This statement on the use of angiotensin receptor blockers (ARBs) and the risk of cancer, was made in response to a publication reporting that ARBs may be associated with a modestly increased risk of incident cancer.